Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)
China · Delayed Price · Currency is CNY 24.84
-0.34 (-1.35%)
At close: Sep 9, 2025
SHE:001367 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2020 |
Net Income | 125.31 | 122.56 | 104.67 | 107.59 | 94 | 62.83 | Upgrade |
Depreciation & Amortization | 18.23 | 16.51 | 13.41 | 14.3 | 13.03 | 10.64 | Upgrade |
Other Amortization | 0.93 | 0.78 | 1.99 | 1.68 | 1.71 | 0.99 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | 0.24 | - | - | - | Upgrade |
Asset Writedown & Restructuring Costs | 1.21 | 1.23 | 0.96 | 1.21 | 0.67 | 0.24 | Upgrade |
Loss (Gain) From Sale of Investments | -3.57 | -3 | -0.32 | 3.85 | -1.45 | -3.59 | Upgrade |
Provision & Write-off of Bad Debts | 0.96 | 0.09 | 0.43 | 1.09 | -0.27 | -0.64 | Upgrade |
Other Operating Activities | 1.25 | 0.6 | 1.6 | -7.45 | 4.29 | 4.42 | Upgrade |
Change in Accounts Receivable | -1.55 | -27.23 | -20.56 | 11.11 | -22.35 | 10.7 | Upgrade |
Change in Inventory | 28.53 | 37.64 | -19.1 | -38.88 | -20.63 | -18.4 | Upgrade |
Change in Accounts Payable | -7.94 | 11.19 | -4.6 | -19.29 | 36.22 | 8.25 | Upgrade |
Change in Other Net Operating Assets | 4.85 | 5.77 | -0.08 | 0.22 | -0.24 | 0.53 | Upgrade |
Operating Cash Flow | 166.34 | 167.16 | 80.62 | 74.95 | 107.04 | 76.49 | Upgrade |
Operating Cash Flow Growth | 13.59% | 107.35% | 7.56% | -29.98% | 39.93% | 63.07% | Upgrade |
Capital Expenditures | -156.97 | -64.75 | -57.44 | -20.19 | -33.32 | -21.02 | Upgrade |
Sale of Property, Plant & Equipment | - | - | 0.12 | - | 0 | - | Upgrade |
Investment in Securities | -236.43 | 3 | 0.32 | -0.99 | -1.21 | 48.84 | Upgrade |
Investing Cash Flow | -393.4 | -61.75 | -57 | -21.18 | -34.52 | 27.83 | Upgrade |
Long-Term Debt Repaid | - | -1.86 | -1.04 | -1.15 | -0.88 | - | Upgrade |
Total Debt Repaid | -1.86 | -1.86 | -1.04 | -1.15 | -0.88 | - | Upgrade |
Net Debt Issued (Repaid) | -1.86 | -1.86 | -1.04 | -1.15 | -0.88 | - | Upgrade |
Issuance of Common Stock | 25.46 | 25.46 | 698.45 | - | - | - | Upgrade |
Common Dividends Paid | -18.34 | -34 | - | -0.71 | -16.43 | -53.89 | Upgrade |
Other Financing Activities | - | - | -24.08 | -1.9 | -1.4 | - | Upgrade |
Financing Cash Flow | 5.27 | -10.39 | 673.33 | -3.77 | -18.71 | -53.89 | Upgrade |
Foreign Exchange Rate Adjustments | 2.06 | 2.68 | 0.61 | 5.52 | -1.46 | -1.97 | Upgrade |
Net Cash Flow | -219.74 | 97.69 | 697.55 | 55.52 | 52.35 | 48.46 | Upgrade |
Free Cash Flow | 9.36 | 102.41 | 23.17 | 54.76 | 73.72 | 55.48 | Upgrade |
Free Cash Flow Growth | -88.71% | 341.91% | -57.68% | -25.73% | 32.89% | 91.61% | Upgrade |
Free Cash Flow Margin | 1.86% | 21.72% | 5.83% | 12.95% | 18.95% | 19.48% | Upgrade |
Free Cash Flow Per Share | 0.06 | 0.68 | 0.17 | 0.49 | 0.66 | 0.50 | Upgrade |
Cash Income Tax Paid | 22.65 | 19.27 | 33.38 | 5.24 | 12.89 | 9.94 | Upgrade |
Levered Free Cash Flow | 9.85 | 84.18 | -18.14 | -2.35 | 44.27 | 31.09 | Upgrade |
Unlevered Free Cash Flow | 10.08 | 84.41 | -18.12 | -2.31 | 44.34 | 31.09 | Upgrade |
Change in Working Capital | 22 | 28.39 | -42.36 | -47.31 | -4.94 | 1.61 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.